FiercePharma

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...
Medscape

Complications Associated With Arterial Catheterization in Children.

Objectives: To examine the prevalence of and risk factors associated with arterial catheterization complications in a large pediatric patient population in an effort to generate hypotheses for future ...
Business Wire

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a BTG International group company (BTG plc (LSE:BTG)), announced the publication of results of the SEATTLE II trial in the JACC: Cardiovascular ...
Business Wire

Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS ® Therapy Protocols for Pulmonary Embolism

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how ...
Nature

Complications associated with central and non-central venous catheters in a neonatal intensive care unit

The objective of this study is to compare complication rates between peripherally inserted central catheters (PICCs) and peripherally inserted non-central catheters (PINCCs) in the neonatal intensive ...
Medscape

Complications Associated With Arterial Catheterization in Children.

In this study, we quantified the risk and described the risk factors for complications associated with arterial catheterization in critically ill children. We already know that central venous ...